Search Results - "Alvarado Fernández, MD"

5PSQ-063 Persistence of tyrosine kinase inhibitors in advanced renal cell carcinoma by Guzman Ramos, MI, Barriga Rodríguez, P, Alvarado Fernández, MD, García Giménez, I, Santos Rubio, MD

“…Background and importanceTyrosine kinase inhibitors (TKI) are increasingly used as oral targeted therapies in oncology, where advanced renal cell carcinoma…”
Get full text

5PSQ-038 Safety of cyclin dependent kinase inhibitors in the treatment of breast cancer with positive hormonal receptors and negative human epidermal growth factor receptor 2 by Rendón De Lope, L, Castillo-Martin, C, Alvarado Fernández, MD, Castillejo García, R, Martinez Suarez, A, Cordero Ramos, J

“…Background and importanceCyclin dependent kinase (CDK) inhibitors are an innovative therapeutic target for the treatment of locally advanced or metastatic…”
Get full text

5PSQ-154 Determination of genetic polymorphisms of the dihydropyrimidine dehydrogenase gene in real clinical practice as predictors of severe fluoropyrimidine associated toxicity by Alvarado Fernández, MD, Rendón De Lope, L, Villalobos Torres, L, Marcos Rodriguez, JA, Castillo-Martin, C, Murillo Izquierdo, M

“…Background and importanceFluoropyrimidines are antineoplastic drugs used for the treatment of many types of solid tumours. Approximately 80–90% administered is…”
Get full text

5PSQ-061 Determination of genetic polymorphisms of the dihydropyrimidine dehydrogenase gene in real clinical practice: posological individualisation by Alvarado Fernández, MD, Murillo Izquierdo, M, Cordero Ramos, J, Rendón de Lope, L, Rengifo, MDLCDonoso, Moya Martin, ML

“…BackgroundFluoropyrimidines are antineoplastic drugs used for the treatment of many types of solid tumours. Approximately 80%–90% administered are metabolised…”
Get full text

3PC-066 Compounding an eye drop formulation of topical insulin for corneal defects refractory to previous treatment: experience in real clinical practice by Alvarado Fernandez, MD, Montero Pérez, O, García Giménez, I, Peláez Bejarano, A, Robustillo Cortés, MA

“…Background and importanceRecent studies suggest the use of topical insulin on the ocular surface to accelerate cicatrisation of corneal lesions in diverse…”
Get full text

DI-094 Botulinum toxin type a for the treatment of neurological diseases: drug utilisation review by Ramos, J Cordero, Fernández, MD Alvarado, Martínez, S Santana, Izquierdo, M Murillo, Aznar, MD Guerrero

“…BackgroundNeurology is one of the medical specialities in which botulinum toxin (BT) provides greater therapeutic benefits due to its ability to produce muscle…”
Get full text

DI-080 Study of the use of canakinumab in muckle–wells syndrome in a tertiary hospital by Guerrero, L Jiménez, Macias, I Castañeda, Fernández, MD Alvarado, Izquierdo, M Murillo, del Castillo, S Sandoval Fernández

“…BackgroundCanakinumab is a IgG1 anti-interleukin-1β monoclonal antibody indicated in the treatment of Muckle–Wells syndrome (MWS). It is an autosomal dominant…”
Get full text

3PC-011 Effectiveness of 3% topical imiquimod in off-label use for oral florida papillomatosis: a case report by Rendón de Lope, L, Ruiz Huertas, P, Donoso-Rengifo, C, Murillo Izquierdo, M, Castillo Martin, C, Cordero Ramos, J, Alvarado Fernandez, MD, Fernandez Gonzalez, M, Moya Martin, ML

“…BackgroundImiquimod is an immunomodulator, with antitumour activity, indicated for the treatment of genital and perianal warts produced by the human papilloma…”
Get full text

PS-058 Analysis of pharmaceutical interventions in the onco-haematology area in a tertiary level hospital by Carreño, E Romero, Rodríguez, JA Marcos, Guerrero, L Jiménez, Rengifo, C Donoso, Martínez, S Santana, Fernández, MD Alvarado, Real, M Vázquez

“…BackgroundChemotherapy prescriptions validation by the oncology pharmacist often require interventions to optimise some aspects of the treatment, usually…”
Get full text

Natural orifice transluminal endoscopic surgery to the rescue: retrieval of an extraluminally migrated lumen-apposing metal stent by Alvarado-Fernandez, Victor, Vargas-Madrigal, Jorge

“…[Display omitted]…”
Get full text

5PSQ-004 Observational study of the evolution of blood glucose levels after the change to insulin degludec by Moya-Martin, ML, Castillo-Martin, C, Fernandez-Gonzalez, M, Donoso-Rengifo, C, Rendón de Lope, L, Cordero-Ramos, J, Murillo-Izquierdo, M, Alvarado-Fernandez, MD, Santana-Martinez, S, Romero-Carreño, E

“…BackgroundDegludec is a new-generation basal insulin analogue with a longer acting, better pharmacokynetic and pharmacodynamic profile and with four times less…”
Get full text